ASCO Continues to Support 21st Century Cures

Get Permission

The U.S. House of Representatives passed monumental legislation that will accelerate the discovery, development, and delivery of promising new cancer treatments. The 21st Century Cures Act advances big data and precision medicine and strengthens the National Institutes of Health and Food and Drug Administration.

ASCO has weighed in heavily throughout the development of this legislation and will continue to work closely with lawmakers on its advancement. ASCO encourages the passage of this legislation in the U.S. Senate this fall.

The 21st Century Cures legislation will help foster big data advancements, like ASCO’s CancerLinQ™, a cutting-edge health information technology platform that will revolutionize how we care for people with cancer, and the Targeted Agent and Profiling Utilization Registry (TAPUR) Study, ­ASCO’s first-ever clinical trial, designed to learn from the real-world practice of precision medicine. ■

© 2015. American Society of Clinical Oncology. All rights reserved.





By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.